Time-Restricted Eating Versus Nutritional Counseling for the Reduction of Radiation or Chemoradiation Tx Side Effects in Patients With Prostate, Cervical, or Rectal Cancers
NCT05722288 · Status: RECRUITING · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 60
Last updated 2025-08-29
Summary
This phase II trial studies how well time-restricted eating works in reducing side effects of radiation or chemoradiation side effects when compared to nutritional counseling among patients with prostate, cervical, and rectal cancers. Time-restricted eating, also called short term fasting or intermittent fasting, is an eating plan that alternates between not eating food (fasting) and non-fasting periods. Nutritional counseling involves being asked to follow a healthy, balanced diet that includes instructions on what kinds of food are better tolerated during radiation and chemoradiation therapy. This trial may help researchers determine if certain diets may improve the anti-cancer effects of radiation therapy and reduce the side-effects of this treatment. If successful, these diets may be integrated into the future treatment of prostate, cervical, and rectal cancers.
Conditions
- Localized Prostate Carcinoma
- Locally Advanced Cervical Carcinoma
- Locally Advanced Rectal Carcinoma
- Malignant Solid Neoplasm
- Recurrent Prostate Carcinoma
- Stage I Prostate Cancer AJCC v8
- Stage IB Cervical Cancer FIGO 2018
- Stage IB2 Cervical Cancer FIGO 2018
- Stage II Prostate Cancer AJCC v8
- Stage II Rectal Cancer AJCC v8
- Stage IIA Cervical Cancer FIGO 2018
- Stage IIB Cervical Cancer FIGO 2018
- Stage III Prostate Cancer AJCC v8
- Stage III Rectal Cancer AJCC v8
- Stage IIIA Cervical Cancer FIGO 2018
- Stage IIIB Cervical Cancer FIGO 2018
- Stage IIIC Cervical Cancer FIGO 2018
- Stage IVA Prostate Cancer AJCC v8
Interventions
- PROCEDURE
-
Biospecimen Collection
Undergo collection of blood
- OTHER
-
Informational Intervention
Receive nutritional counseling
- OTHER
-
Quality-of-Life Assessment
Ancillary studies
- OTHER
-
Questionnaire Administration
Ancillary studies
- BEHAVIORAL
-
Short-Term Fasting
Undergo time-restricted eating
Sponsors & Collaborators
-
National Cancer Institute (NCI)
collaborator NIH -
City of Hope Medical Center
lead OTHER
Principal Investigators
-
Yun R Li · City of Hope Medical Center
Study Design
- Allocation
- RANDOMIZED
- Purpose
- SUPPORTIVE_CARE
- Masking
- NONE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2023-01-20
- Primary Completion
- 2026-07-20
- Completion
- 2026-07-20
Countries
- United States
Study Locations
More Related Trials
-
Medical Nutrition Therapy or Standard Care in Treating Patients With Lung Cancer, Pancreatic Cancer, or Stage III or Stage IV Prostate Cancer
NCT00769652 ·Status: TERMINATED ·Phase: NA
-
Feasibility of Intermittent Fasting During Chemotherapy
NCT06645093 ·Status: ENROLLING_BY_INVITATION ·Phase: NA
-
A Study of Cancer Related Fatigue in Patients With Metastatic Cancer Receiving Anti-PD1 Immunotherapy
NCT03525873 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3
-
Metabolic and Immunological Effects of a Modified Fasting Regimen in Cancer Patients
NCT05748704 ·Status: RECRUITING ·Phase: NA
-
Multimodal Intervention for Cachexia in Advanced Cancer Patients Undergoing Chemotherapy
NCT02330926 ·Status: COMPLETED ·Phase: PHASE3
-
Nutrition and Pharmacological Algorithm for Oncology Patients Study
NCT04155008 ·Status: TERMINATED ·Phase: PHASE4
-
A Case Crossover Study of Intermittent Fasting in CLL/SLL
NCT05708326 ·Status: COMPLETED ·Phase: NA
-
Megestrol to Limit Weight Loss and Improve Quality of Life in Treating Patients With Head and Neck Cancer
NCT00006799 ·Status: COMPLETED ·Phase: PHASE3
-
Effect of Standardized Nutrient Management on Clinical Outcomes of Hematopoientic Stem Cell Transportation Patients
NCT04591340 ·Status: UNKNOWN
-
A Pilot, Feasibility Study of Intermittent Caloric Restriction Plus Plant-based Diet in Cancer Patients Receiving Chemotherapy
NCT05359848 ·Status: RECRUITING ·Phase: NA
-
Low Antioxidant Diet in Controlling Cachexia in Patients With Oropharyngeal Cancer Receiving Chemotherapy and Radiation Therapy
NCT00486304 ·Status: COMPLETED ·Phase: PHASE1
-
Nutritional Preferences and Product Accessibility in Oral Nutritional Supplements in Participants With Breast, Colorectal, Upper Gastrointestinal, or Prostate Cancer
NCT03563352 ·Status: WITHDRAWN
-
Fasting Mimicking Diet (FMD) in Conjunction With Chemotherapy in Advanced Ovarian Cancer
NCT05921149 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Comparison of Nutritional Supplements in Preventing Weight Loss in Patients With Cancer
NCT00053053 ·Status: COMPLETED ·Phase: PHASE3
-
Nutritional Risk and Mucositis in Patients With Head and Neck Carcinoma Receiving Chemoradiation
NCT00577902 ·Status: COMPLETED
-
Fasting Mimicking Diet for Reducing Immune Related Adverse Events for Cancer Patients on Immune Checkpoint Inhibitors, FMD-ICI Trial
NCT06438588 ·Status: RECRUITING ·Phase: NA
-
Megestrol in Treating Patients Who Are Undergoing Radiation Therapy for Lung Cancer
NCT00031785 ·Status: COMPLETED ·Phase: PHASE3
-
Radiation Therapy, Chemotherapy, and Soy Isoflavones in Treating Patients With Stage IIIA-IIIB Non-Small Cell Lung Cancer
NCT01958372 ·Status: COMPLETED ·Phase: PHASE1
-
Physical Activity and Dexamethasone in Reducing Cancer-Related Fatigue in Patients With Advanced Cancer
NCT02491632 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2/PHASE3
-
Safety and Feasibility of Fasting While Receiving Chemotherapy
NCT00757094 ·Status: COMPLETED
-
Short-Term Fasting: Impact on Toxicity
NCT00936364 ·Status: TERMINATED ·Phase: NA
-
The RECHARGE Low Carbohydrate Diet Trial for Metastatic Cancer
NCT00444054 ·Status: COMPLETED ·Phase: NA
-
Frequency of Cachexia in Ambulatory Cancer Patients and Psychological Burden in Patients and Their Primary Caregivers
NCT04090619 ·Status: ACTIVE_NOT_RECRUITING
-
Developmental Study on Fatigue in Cancer
NCT00034450 ·Status: COMPLETED ·Phase: PHASE2
-
Early Oral Supplementation in Improving Nutritional Status in Patients Undergoing Hematopoietic Stem Cell Transplant
NCT02590107 ·Status: TERMINATED ·Phase: NA